On January 20, 1990, when the nuclear reactor at McClellan Air Force Base achieved its first sustained nuclear reaction known as “criticality,” it was the newest reactor in the United States.
Six years later, when the Tennessee Valley Authority launched the Watts Bar Nuclear Generating Station, the nuclear reactor at McClellan was relegated to second newest. McClellan would go on to retain that ranking for another two decades until this past October when the Tennessee Valley Authority launched Watts Bar Unit 2.
The UC Davis-based EXPLORER consortium, which aims to build a revolutionary total-body PET (positron emission tomography) scanner, has announced the selection of two industry partners to help build the prototype device. They are United Imaging Healthcare America, a North American subsidiary of Shanghai United Imaging Healthcare, and SensL Technologies of Cork, Ireland.
Positron emission tomography, or PET, scanning uses short-lived radioactive tracers to show how organs and tissues are functioning in the body, while magnetic resonance imaging (MRI) and computed tomography (CT) scans mostly show anatomy. PET scans are widely used to diagnose and track a variety of illnesses, including cancer, heart disease and Alzheimer’s disease.
Solar cells made from perovskites have sparked great excitement in recent years because the crystalline compounds boast low production costs and high energy efficiencies. Now UC Davis scientists have found that some promising compounds — the hybrid lead halide perovskites — are chemically unstable and may be unsuited for solar cells.
“We have proven these materials are highly unlikely to function on your rooftop for years,” said Alexandra Navrotsky, interdisciplinary professor of ceramic, earth, and environmental materials chemistry at UC Davis and director of the Nanomaterials in the Environment, Agriculture, and Technology (NEAT) organized research unit.
Our electronic devices are based on what happens when different materials are layered together: “The interface is the device,” as Nobel laureate Herbert Kroemer famously claimed over 40 years ago. Right now, our microchips and memory devices are based on the movement of electrons across and near interfaces, usually of silicon, but with limitations of conventional electronics become apparent, researchers are looking at new ways to store or process information. These “heterostructures” can also find applications in advanced batteries and fuel cells.
Now physicists at UC Davis have observed what’s going on at some of these interfaces as oxygen ions react with different metals, causing drastic changes in magnetic and electronic properties.
Audio: Listen to a version of this story on the Three Minute Egghead podcast.
How many projects can you work on at the same time, before losing efficiency? There are many reasons to get involved in multiple projects – impress your boss, gain personal satisfaction, help out colleagues or just because you’re interested. But at some point, there must be one project too many.
“There is a limit,” said Bogdan Vasilescu, postdoctoral researcher in the DECAL lab at the UC Davis Department of Computer Science. “Multitasking fills time that’s otherwise unused, but there is a limit at four or five projects in a week.”
Within just a few years, we’ve got used to controlling devices by swiping, scrolling or tapping our fingers on a touch screen. But soon you might not even have to touch anything at all to check your email or play a video – just wave your hand in the air, thanks to ultrasonic technology from Chirp Microsystems, a startup company founded in 2013 by researchers from UC Davis and UC Berkeley.
Chirp’s technology is “disruptive” in the ultrasound area, said David Horsley, professor of electrical and computer engineering at UC Davis and co-founder of the company. Chirp’s ultrasound transducers are smaller and operate with much lower power needs than any currently available.
A new virus-killing peptide springs from an unexpected source: another virus, Hepatitis C.
Now biomedical engineers at UC Davis and Nanyang Technological University, Singapore show how the HCV alpha-helical (AH) peptide can make holes in the types of membranes that surround viruses. The work is published Jan. 5 in Biophysical Journal.
HCV-AH is known to be active against a wide range of viruses including West Nile, dengue, measles and HIV.
The HCV-AH peptide appears to target an Achilles’ heel common to many viruses, most likely a property of the lipid coating or envelope, said study author Atul Parikh, professor of biomedical engineering at UC Davis. That means that it’s less likely that viruses can readily evolve to become resistant to the peptide.
As 2015 draws to a close, a team of UC Davis undergraduates can look back with pride and a sigh of relief on one of the most grueling but rewarding experiences of their college career.
Students Gabriel Freund, Muntaha Samad, Andrew Shepherd, Logan Vinson and Joanne Wu, were selected last spring as members of UC Davis’ 2015 iGEM (International Genetically Engineered Machines) team. They were joined by Andrew Michelmore, who is from Davis but attends Santa Clara University.
A team of researchers from the University of California, Davis and the University of Washington have demonstrated that the conductance of DNA can be modulated by controlling its structure, thus opening up the possibility of DNA’s future use as an electromechanical switch for nanoscale computing. Although DNA is commonly known for its biological role as the molecule of life, it has recently garnered significant interest for use as a nanoscale material for a wide-variety of applications.
Thermal ablation with magnetic resonance–guided focused ultrasound surgery (MRgFUS) is a noninvasive technique for treating fibroids and cancer. New research from UC Davis shows that combining the technique with chemotherapy can allow complete destruction of tumors in mice.
MRgFUS combines an ultrasound beam that heats and destroys tissue with a magnetic resonance imaging to guide the beam and monitor the effects of treatment. The effectiveness of the treatment can be limited by the need to spare normal tissue or critical structures on the tumor margins, as well as the need to eliminate micrometastases.